Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 3/20 | 0.56 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.36 |
| ▸ | GABRP | O00591 | 2/20 | 0.35 |
| ▸ | GABRD | O14764 | 2/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.35 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.35 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.35 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.35 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.35 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.35 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.35 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.35 |
| ▸ | GABRE | P78334 | 2/20 | 0.35 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.35 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.35 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.35 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.35 |
| ▸ | BHMT | Q93088 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30522084 | 1.00 | DPP4 (0.56) | DPP4SLC7A5DPP9GABRPGABRD | |
| SCHEMBL31688025 | 0.86 | DPP4 (0.42) | DPP4SLC7A5DPP9GABRPGABRD | |
| Hydrochloric Acid SCHEMBL3750493 | 0.84 | DPP4 (0.41) | DPP4SLC7A5DPP9GABRPGABRD | |
| SCHEMBL13847383 | 0.83 | DPP4 (0.56) | DPP4SLC7A5DPP9 | |
| SCHEMBL10908256 | 0.83 | GABRP (0.38) | DPP4SLC7A5DPP9GABRPGABRD | |
| SCHEMBL16774720 | 0.83 | SLC7A5 (0.48) | DPP4SLC7A5GABRPGABRDGABRA1 | |
| SCHEMBL28014783 | 0.83 | SLC7A5 (0.48) | DPP4SLC7A5GABRPGABRDGABRA1 | |
| Hydrochloric Acid SCHEMBL11341606 | 0.81 | DPP4 (0.37) | DPP4SLC7A5DPP9GABRPGABRD | |
| SCHEMBL13981419 | 0.78 | DPP4 (0.40) | DPP4MVD | |
| SCHEMBL21570251 | 0.78 | DPP4 (0.58) | DPP4DPP9GABRPGABRDGABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100152156-A1 | 2-Azetidinone Derivatives For The Treatment Of Hyperlipidaemic Diseases | ASTRAZENECA AB (SE) | 2010-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152156-A1 | 2-Azetidinone Derivatives For The Treatment Of Hyperlipidaemic Diseases | NPC1L1, CYP46A1, PCSK9 | DPP4 205/4885SLC7A5 465/4885DPP9 228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.